Waldemar Pruzanski

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kuksis Arnis; Pruzanski Waldemar
Phase composition of lipoprotein SM/cholesterol/PtdCho affects FA specificity of sPLA2s.
Pruzanski Waldemar
Renal amyloidosis in rheumatoid arthritis.
Pruzanski W; Lambeau G; Lazdunski M; Cho W; Kopilov J; Kuksis A
Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Waldemar Pruzanski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Kuksis Arnis; Pruzanski Waldemar
Phase composition of lipoprotein SM/cholesterol/PtdCho affects FA specificity of sPLA2s.
Journal of lipid research 2008;49(10):2161-8.
2007: Pruzanski Waldemar
Renal amyloidosis in rheumatoid arthritis.
The Journal of rheumatology 2007;34(4):889; author reply 889.
2007: Pruzanski W; Lambeau G; Lazdunski M; Cho W; Kopilov J; Kuksis A
Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2.
Biochimica et biophysica acta 2007;1771(1):5-19.
2006: Pruzanski Waldemar; Kopilov Julia; Kuksis Arnis
Cytokines in collagen disease-related atherogenesis.
The Journal of rheumatology 2006;33(12):2548; author reply 2548-9.
2006: Pruzanski Waldemar
III international conference on osteoporosis in men May 12-14, 2005, Genova, Italy.
The Journal of rheumatology 2006;33(1):158-60.
2005: Pruzanski W; Lambeau L; Lazdunsky M; Cho W; Kopilov J; Kuksis A
Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
Biochimica et biophysica acta 2005;1736(1):38-50.
2005: Pruzanski Waldemar
Phospholipase A2: quo vadis?
The Journal of rheumatology 2005;32(3):400-2.
2002: Muzaffer Mohammed A; Dayer Jean-Michel; Feldman Brian M; Pruzanski Waldemar; Roux-Lombard Pascale; Schneider Rayfel; Laxer Ronald M; Silverman Earl D
Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
The Journal of rheumatology 2002;29(5):1071-8.
2001: Pruzanski W; Stefanski E; Kopilov J; Kuksis A
Mitogenic effect of lipoproteins on human vascular smooth muscle cells: the impact of hydrolysis by gr II A phospholipase A(2).
Laboratory investigation; a journal of technical methods and pathology 2001;81(5):757-65.
2000: Pruzanski W; Stefanski E; de Beer F C; de Beer M C; Ravandi A; Kuksis A
Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins.
Journal of lipid research 2000;41(7):1035-47.
1998: Pruzanski W; Stefanski E; de Beer F C; de Beer M C; Vadas P; Ravandi A; Kuksis A
Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL.
Journal of lipid research 1998;39(11):2150-60.
1998: Pruzanski W; Stefanski E; Vadas P; McNamara T F; Ramamurthy N; Golub L M
Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2.
The Journal of rheumatology 1998;25(9):1807-12.
1998: Pruzanski W; Stefanski E; Vadas P; Kennedy B P; van den Bosch H
Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors.
Biochimica et biophysica acta 1998;1403(1):47-56.
1998: Tepper J L; Feinman S V; D'Costa L; Sooknannan R; Pruzanski W
Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia.
The Journal of rheumatology 1998;25(5):925-8.
1998: Lin M K; Katz A; van den Bosch H; Kennedy B; Stefanski E; Vadas P; Pruzanski W
Induction of secretory phospholipase A2 confirms the systemic inflammatory nature of adjuvant arthritis.
Inflammation 1998;22(2):161-73.
1998: Dan P; Dagan A; Krimsky M; Pruzanski W; Vadas P; Yedgar S
Inhibition of type I and type II phospholipase A2 by phosphatidyl-ethanolamine linked to polymeric carriers.
Biochemistry 1998;37(17):6199-204.
1997: Pruzanski W; Stefanski E; Vadas P; Ramamurthy N S
Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity.
Biochemical pharmacology 1997;53(12):1901-7.
1997: Mace S; Vadas P; Pruzanski W
Anaphylactic shock induced by intraarticular injection of methylprednisolone acetate.
The Journal of rheumatology 1997;24(6):1191-4.
1997: Vadas P; Grouix B; Stefanski E; Wloch M; Pruzanski W; Schroeder J; Gauldie J
Coordinate expression of group II phospholipase A2 and the acute-phase proteins haptoglobin (HP) and alpha1-anti-chymotrypsin (ACH) by HepG2 cells.
Clinical and experimental immunology 1997;108(1):175-80.
1997: Jassal S V; Morton A R; Vadas P; Pruzanski W; Stefanski E; Pierratos A
Pro-inflammatory activity of phospholipase A2 in CAPD patients with and without peritonitis.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1997;17(2):197-9.
1997: Pruzanski W; Kennedy B P; van den Bosch H; Stefanski E; Vadas P
Microtubule depolymerization selectively down-regulates the synthesis of proinflammatory secretory nonpancreatic phospholipase A2.
Laboratory investigation; a journal of technical methods and pathology 1997;76(2):171-8.
1995: Pruzanski W; Bogoch E; Katz A; Wloch M; Stefanski E; Grouix B; Sakotic G; Vadas P
Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes.
The Journal of rheumatology 1995;22(11):2114-9.
1995: Pruzanski W; Urowitz M B; Grouix B; Vadas P
Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritis.
The Journal of rheumatology 1995;22(10):1816-9.
1995: Pruzanski W; de Beer F C; de Beer M C; Stefanski E; Vadas P
Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.
The Biochemical journal 1995;309 ( Pt 2)():461-4.
1995: Vadas P; Stefanski E; Grouix B; Schouten B D; Pruzanski W
Inhibition of human group II phospholipase A2 by C-reactive protein in vitro.
Journal of lipid mediators and cell signalling 1995;11(2):187-200.
1994: Van T; Sussman G; Pruzanski W
Impact of intravenous infusions of low and high doses of gamma globulins (IVIG) on phagocytic functions in adults with primary humoral immunodeficiency.
Inflammation 1994;18(4):419-26.
1994: Pruzanski W; Goulding N J; Flower R J; Gladman D D; Urowitz M B; Goodman P J; Scott K F; Vadas P
Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
The Journal of rheumatology 1994;21(2):252-7.
1993: Vadas P; Schouten B D; Stefanski E; Scott K; Pruzanski W
Association of hyperphospholipasemia A2 with multiple system organ dysfunction due to salicylate intoxication.
Critical care medicine 1993;21(7):1087-91.
1993: Ellies L G; Heersche J N; Pruzanski W; Vadas P; Aubin J E
The role of phospholipase A2 in interleukin-1 alpha-mediated inhibition of mineralization of the osteoid formed by fetal rat calvaria cells in vitro.
Journal of dental research 1993;72(1):18-24.
1992: Pruzanski W; Wilmore D W; Suffredini A; Martich G D; Hoffman A G; Browning J L; Stefanski E; Sternby B; Vadas P
Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.
Inflammation 1992;16(5):561-70.
1992: Pruzanski W; Scott K; Smith G; Rajkovic I; Stefanski E; Vadas P
Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.
Inflammation 1992;16(5):451-7.
1992: Pruzanski W; Greenwald R A; Street I P; Laliberte F; Stefanski E; Vadas P
Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline.
Biochemical pharmacology 1992;44(6):1165-70.
1992: Vadas P; Scott K; Smith G; Rajkovic I; Stefanski E; Schouten B D; Singh R; Pruzanski W
Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock.
Life sciences 1992;50(11):807-11.
1991: Vadas P; Pruzanski W; Farewell V
A predictive model for the clearance of soluble phospholipase A2 during septic shock.
The Journal of laboratory and clinical medicine 1991;118(5):471-5.
1991: Flood D A; Chan C K; Pruzanski W
Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis.
The Journal of rheumatology 1991;18(8):1254-6.
1991: Ellies L G; Heersche J N; Vadas P; Pruzanski W; Stefanski E; Aubin J E
Interleukin-1 alpha stimulates the release of prostaglandin E2 and phospholipase A2 from fetal rat calvarial cells in vitro: relationship to bone nodule formation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991;6(8):843-50.
1991: Vadas P; Pruzanski W; Stefanski E; Ellies L G; Aubin J E; Sos A; Melcher A
Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action.
Immunology letters 1991;28(3):187-93.
1991: Pruzanski W; Saito S; Stefanski E; Vadas P
Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.
Inflammation 1991;15(2):127-35.
1991: Pruzanski W; Bogoch E; Wloch M; Vadas P
The role of phospholipase A2 in the physiopathology of osteoarthritis.
The Journal of rheumatology. Supplement 1991;27():117-9.
1991: Pruzanski W; Bogoch E; Stefanski E; Wloch M; Vadas P
Enzymatic activity and distribution of phospholipase A2 in human cartilage.
Life sciences 1991;48(25):2457-62.
1990: Pruzanski W; Bogoch E; Stefanski E; Wloch M; Vadas P
Synthesis and release of phospholipase A2 by unstimulated human articular chondrocytes.
The Journal of rheumatology 1990;17(10):1386-91.
1990: Pruzanski W; Lee P; Stefanski E; Sternby B; Vadas P
Hypophospholipasemia A2 in systemic sclerosis.
The Journal of rheumatology 1990;17(9):1182-6.
1990: Vadas P; Pruzanski W; Stefanski E; Sternby B
Compartmental heterogeneity of soluble phospholipases A.
Inflammation 1990;14(2):173-83.
1989: Pruzanski W; Saito S; Stylianos S; Jacobs H
Influence of monoclonal IgM cold agglutinins on adhesiveness, phagocytosis, and bactericidal activity on human granulocytes and monocytes.
Inflammation 1989;13(2):201-9.
1989: Vadas P; Pruzanski W; Kim J; Fornasier V
The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.
The American journal of pathology 1989;134(4):807-11.
1988: Pruzanski W; Vadas P
Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis.
The Journal of rheumatology 1988;15(11):1601-3.
1988: Pruzanski W; Keystone E C; Sternby B; Bombardier C; Snow K M; Vadas P
Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis.
The Journal of rheumatology 1988;15(9):1351-5.
1988: Vadas P; Pruzanski W; Stefanski E
Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?
Agents and actions 1988;24(3-4):320-5.
1988: Vadas P; Pruzanski W; Stefanski E; Ruse J; Farewell V; McLaughlin J; Bombardier C
Concordance of endogenous cortisol and phospholipase A2 levels in gram-negative septic shock: a prospective study.
The Journal of laboratory and clinical medicine 1988;111(5):584-90.
1988: Pruzanski W; Saito S
Comparative study of phagocytosis and intracellular bactericidal activity of human monocytes and polymorphonuclear cells. Application of fluorochrome and extracellular quenching technique.
Inflammation 1988;12(1):87-97.
1988: Pruzanski W; Saito S; Alam M; Ranadive N S
Influence of cationic superoxide generation enhancing protein (SGEP) on phagocytic and intracellular bactericidal activity of human polymorphonuclear cells.
Inflammation 1988;12(1):99-106.
1988: Vadas P; Pruzanski W; Stefanski E; Sternby B; Mustard R; Bohnen J; Fraser I; Farewell V; Bombardier C
Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse.
Critical care medicine 1988;16(1):1-7.
1988: Pruzanski W; Vadas P; Kim J; Jacobs H; Stefanski E
Phospholipase A2 activity associated with synovial fluid cells.
The Journal of rheumatology 1988;15(5):791-4.
1987: Pruzanski W; Jacobs H; Saito S; Donnelly E M; Lui L C
Cryptic cold agglutinin activity of monoclonal macroglobulins.
American journal of hematology 1987;26(2):167-74.
1986: Stefanski E; Pruzanski W; Sternby B; Vadas P
Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis.
Journal of biochemistry 1986;100(5):1297-303.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Waldemar Pruzanski

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Phenomena

Living Beings

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Waldemar Pruzanski (preview)

All Publications